HeiLongJiang ZBD Pharmaceutical Co (SHSE:603567) Days Sales Outstanding : 632.00 (As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is HeiLongJiang ZBD Pharmaceutical Co Days Sales Outstanding?

HeiLongJiang ZBD Pharmaceutical Co's average Accounts Receivable for the three months ended in Mar. 2025 was ¥3,250 Mil. HeiLongJiang ZBD Pharmaceutical Co's Revenue for the three months ended in Mar. 2025 was ¥469 Mil. Hence, HeiLongJiang ZBD Pharmaceutical Co's Days Sales Outstanding for the three months ended in Mar. 2025 was 632.00.

The historical rank and industry rank for HeiLongJiang ZBD Pharmaceutical Co's Days Sales Outstanding or its related term are showing as below:

SHSE:603567' s Days Sales Outstanding Range Over the Past 10 Years
Min: 25.48 Med: 189.47 Max: 579.67
Current: 579.67

During the past 13 years, HeiLongJiang ZBD Pharmaceutical Co's highest Days Sales Outstanding was 579.67. The lowest was 25.48. And the median was 189.47.

SHSE:603567's Days Sales Outstanding is ranked worse than
98.54% of 957 companies
in the Drug Manufacturers industry
Industry Median: 72.09 vs SHSE:603567: 579.67

HeiLongJiang ZBD Pharmaceutical Co's Days Sales Outstanding increased from Mar. 2024 (229.24) to Mar. 2025 (632.00).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

HeiLongJiang ZBD Pharmaceutical Co Days Sales Outstanding Historical Data

The historical data trend for HeiLongJiang ZBD Pharmaceutical Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HeiLongJiang ZBD Pharmaceutical Co Days Sales Outstanding Chart

HeiLongJiang ZBD Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Days Sales Outstanding

Get a 7-Day Free Trial

219.53

247.79

263.85

306.01

370.92

HeiLongJiang ZBD Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Days Sales Outstanding	Get a 7-Day Free Trial															229.24	549.17	823.63	430.10	632.00

Competitive Comparison of HeiLongJiang ZBD Pharmaceutical Co's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, HeiLongJiang ZBD Pharmaceutical Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HeiLongJiang ZBD Pharmaceutical Co's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HeiLongJiang ZBD Pharmaceutical Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where HeiLongJiang ZBD Pharmaceutical Co's Days Sales Outstanding falls into.

Save Embed

;

Save Embed

;

HeiLongJiang ZBD Pharmaceutical Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

HeiLongJiang ZBD Pharmaceutical Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2024 is calculated as

	Days Sales Outstanding (A: Dec. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )	/	Revenue (A: Dec. 2024 )	*	Days in Period
=	( (2407.463	+	3093.309)	/	2 )	/	2706.504	*	365
=	2750.386					/	2706.504	*	365
=	370.92

HeiLongJiang ZBD Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding (Q: Mar. 2025 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2024 )	+	Accounts Receivable (A: Mar. 2025 ))	/	count )	/	Revenue (A: Mar. 2025 )	*	Days in Period
=	( (3093.309	+	3407.093)	/	2 )	/	469.27	*	365 / 4
=	3250.201					/	469.27	*	365 / 4
=	632.00

HeiLongJiang ZBD Pharmaceutical Co (SHSE:603567) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

HeiLongJiang ZBD Pharmaceutical Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of HeiLongJiang ZBD Pharmaceutical Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

HeiLongJiang ZBD Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HeiLongJiang ZBD Pharmaceutical Co Ltd (SHSE:603567) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

N/A

Address

No. 72, Hongxing Street, Hulin Town, Heilongjiang Province, Hulin, CHN, 158400

Website

http://www.zbdzy.com

HeiLongJiang ZBD Pharmaceutical Co Ltd operates as a pharmaceutical manufacturer. The business scope of the company includes wholesale, retail, traditional Chinese medicine decoction pieces, Chinese medicine formula granules, Chinese herbal medicine trade, medical equipment, sanitary materials, and inspection and testing.

Executives

Li Tian Zhu	senior management
Zhang Zhong Fang	Director
Wang Lei	senior management
Yan Jiu Jiang	Directors, senior managers
Li Xiu Zhen	senior management
Li Xue Dong	Supervisors

HeiLongJiang ZBD Pharmaceutical Co Headlines

No Headlines